Recombinant factor VIIa (NovoSeven®) restores deficient coagulation: Experience from an ex vivo model
- 1 October 2001
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 38, 10-14
- https://doi.org/10.1016/s0037-1963(01)90141-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation ClinicsArchives of internal medicine (1960), 1996
- Oral Anticoagulants and Intracranial HemorrhageStroke, 1995
- Platelet concentrates promote procoagulant activity: evidence from experimental studies using a perfusion techniqueTransfusion, 1995
- Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Suitability of low-molecular-weight heparin(oid)s and a pentasaccharide for an in vitro human thrombosis model.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- The role of the Baumgartner technique in transfusion medicine: research and clinical applicationsTransfusion, 1994
- Bleeding complications in oral anticoagulant therapy. An analysis of risk factorsArchives of internal medicine (1960), 1993
- Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitorAmerican Journal of Hematology, 1989
- Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects.Journal of Clinical Investigation, 1986
- The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombiMicrovascular Research, 1973